Furthermore, we assessed the presence of a pathogenic variant in BRCA1/2 in first-degree relatives, of a proven carrier, who had developed endometrial cancer without previous breast or synchronous ovarian cancer. Here, BRCA1 is linked to ovarian carcinoma.